儿童静脉黏菌素剂量推荐:一项前瞻性多中心群体药代动力学研究
该前瞻性多中心群体药代动力学研究纳入79例儿童患者(中位年龄2.6岁,92.4%入住ICU),共获取334个血浆黏菌素浓度,用Phoenix 64 version 8.3进行PPK分析。黏菌素药代动力学以一室模型加一级消除充分描述,血清肌酐(SCr)是黏菌素清除率的显著协变量。模拟显示推荐剂量5 mg CBA/kg/日达到目标Css,avg 2 mg/l的概率仅为18.2-63.0%;当目标Css,avg降至1 mg/l时,SCr 0.1-0.3 mg/dl儿童用7.5 mg CBA/kg/日、SCr>0.3 mg/dl儿童用5 mg CBA/kg/日即可达标。结论认为儿童黏菌素剂量应根据患者SCr水平和所需目标Css,avg选择。
要点
- 儿童黏菌素清除率受血清肌酐显著影响,剂量选择需依据SCr水平和目标Css,avg。
- 推荐剂量5 mg CBA/kg/日达到目标Css,avg 2 mg/l的概率仅18.2-63.0%。
- 目标Css,avg 1 mg/l时,SCr 0.1-0.3 mg/dl儿童用7.5 mg CBA/kg/日可达标。
- 目标Css,avg 1 mg/l时,SCr>0.3 mg/dl儿童用5 mg CBA/kg/日可达标。
- 研究纳入79例儿童(中位年龄2.6岁),92.4%入住ICU,共334个血浆黏菌素浓度。
适用人群与场景
- 儿童患者,中位年龄2.6岁(四分位距0.8-6.8岁),73例(92.4%)入住重症监护病房。
诊断标准与关键阈值
- 目标血浆黏菌素平均稳态浓度(Css,avg)设为2 mg/l或1 mg/l。
- 按血清肌酐(SCr)水平分层:0.1-0.3 mg/dl与>0.3 mg/dl。
处置流程与药物剂量
- 目标Css,avg 1 mg/l时,SCr 0.1-0.3 mg/dl的儿童给予7.5 mg CBA/kg/日静脉黏菌素可达标。
- 目标Css,avg 1 mg/l时,SCr>0.3 mg/dl的儿童给予5 mg CBA/kg/日静脉黏菌素可达标。
- 目标Css,avg 2 mg/l时,推荐剂量5 mg CBA/kg/日达到目标的概率为18.2-63.0%。
研究设计与关键结果
- 前瞻性多中心群体药代动力学研究,纳入79例儿童患者,共334个血浆黏菌素浓度。
- 黏菌素药代动力学以一室模型加一级消除充分描述,血清肌酐是黏菌素清除率的显著协变量。
- 模拟显示5 mg CBA/kg/日达到目标Css,avg 2 mg/l的概率为18.2-63.0%。
- 目标Css,avg 1 mg/l时,SCr 0.1-0.3 mg/dl儿童用7.5 mg CBA/kg/日、SCr>0.3 mg/dl儿童用5 mg CBA/kg/日可达标。
证据类型、等级与局限
- 证据类型:前瞻性多中心群体药代动力学研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 儿童静脉黏菌素剂量应根据患者SCr水平和所需目标Css,avg选择,而非统一使用5 mg CBA/kg/日。
- 若目标Css,avg为2 mg/l,5 mg CBA/kg/日的达标概率仅18.2-63.0%,作者据此提出按SCr分层选剂量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to describe the population pharmacokinetics of intravenous colistin use in children and to propose optimal dosage regimens.
METHODS: A prospective, multicenter, population pharmacokinetic (PPK) study was conducted. Phoenix 64 version 8.3 was used for the PPK analysis. Simulations were performed to estimate the probability of target attainment for patients achieving target plasma colistin average steady-state concentrations (Css,avg).
RESULTS: A total of 334 plasma colistin concentrations were obtained from 79 pediatric patients with a median age (interquartile range) of 2.6 years (0.8-6.8 years); 73 (92.4%) were admitted to intensive care units. Colistin pharmacokinetics were adequately described by a one-compartment model with first-order elimination along with serum creatinine (SCr) as a significant covariate in colistin clearance. The simulation demonstrated that the recommended dose of 5 mg of colistin base activity (CBA)/kg/day resulted in 18.2-63.0% probability of achieving a target Css,avg of 2 mg/l. With a lower targeted Css,avg of 1 mg/l, colistin dosing with 7.5 mg and 5 mg of CBA/kg/day were adequate for children with SCr levels of 0.1-0.3 mg/dl and >0.3 mg/dl, respectively.
CONCLUSIONS: SCr is a significant covariate in colistin clearance in children. Colistin dosing should be selected according to the patient's SCr level and the desired target Css,avg.
参考来源
- Wacharachaisurapol N, Sukkummee W, Anunsittichai O, et al. Dose recommendations for intravenous colistin in pediatric patients from a prospective, multicenter, population pharmacokinetic study. Int J Infect Dis. 2021. PMID: 34192578. doi:10.1016/j.ijid.2021.06.052
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。